Group One Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-32,400
| Closed | -$110K | – | 5831 |
|
|
2018
Q3 | $110K | Sell |
32,400
-900
| -3% | -$3.25K | ﹤0.01% | 3471 |
|
|
2018
Q2 | $125K | Sell |
33,300
-40,500
| -55% | -$197K | ﹤0.01% | 3411 |
|
|
2018
Q1 | $302K | Sell |
73,800
-93,200
| -56% | -$434K | ﹤0.01% | 2453 |
|
|
2017
Q4 | $777K | Sell |
167,000
-43,800
| -21% | -$241K | 0.01% | 1912 |
|
|
2017
Q3 | $1.5M | Buy |
210,800
+80,100
| +61% | +$576K | 0.01% | 1263 |
|
|
2017
Q2 | $945K | Buy |
130,700
+6,500
| +5% | +$40.6K | 0.01% | 1500 |
|
|
2017
Q1 | $765K | Sell |
124,200
-100,600
| -45% | -$551K | 0.01% | 1536 |
|
|
2016
Q4 | $1.32M | Buy |
224,800
+101,900
| +83% | +$557K | 0.01% | 1153 |
|
|
2016
Q3 | $653K | Buy |
122,900
+80,400
| +189% | +$434K | 0.01% | 1612 |
|
|
2016
Q2 | $281K | Sell |
42,500
-2,900
| -6% | -$16.2K | ﹤0.01% | 2168 |
|
|
2016
Q1 | $212K | Sell |
45,400
-187,100
| -80% | -$747K | ﹤0.01% | 2280 |
|
|
2015
Q4 | $1.17M | Buy |
232,500
+20,800
| +10% | +$98.8K | 0.01% | 1208 |
|
|
2015
Q3 | $745K | Sell |
211,700
-28,900
| -12% | -$194K | 0.01% | 1477 |
|
|
2015
Q2 | $2.4M | Buy |
240,600
+80,700
| +50% | +$865K | 0.03% | 642 |
|
|
2015
Q1 | $2.04M | Sell |
159,900
-122,200
| -43% | -$1.57M | 0.03% | 626 |
|
|
2014
Q4 | $3.99M | Buy |
282,100
+31,700
| +13% | +$491K | 0.06% | 370 |
|
|
2014
Q3 | $3.44M | Buy |
250,400
+37,600
| +18% | +$576K | 0.05% | 427 |
|
|
2014
Q2 | $3.27M | Sell |
212,800
-114,300
| -35% | -$1.62M | 0.05% | 452 |
|
|
2014
Q1 | $5.57M | Sell |
327,100
-142,400
| -30% | -$2.15M | 0.09% | 197 |
|
|
2013
Q4 | $6.08M | Buy |
469,500
+133,700
| +40% | +$1.6M | 0.09% | 204 |
|
|
2013
Q3 | $3.39M | Sell |
335,800
-70,700
| -17% | -$629K | 0.06% | 325 |
|
|
2013
Q2 | $3.04M | Buy |
+406,500
| New | +$3.18M | 0.07% | 261 |
|
Group One Trading's KERX Position: Q4 2018 in Review
Group One Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 6,876 shares — an estimated $23K sold.
Group One Trading first reported a position in KERX in Q2 2013 and held it in 21 quarters. The position peaked at $4.35M in Q4 2013. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Group One Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Group One Trading sold 6,876 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $23K.
- Group One Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 21 quarters.
- Group One Trading's Keryx Biopharmaceuticals Inc position peaked at $4.35M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.